Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism

Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention. The objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of pulmonary thromboembolism (PTE) on the long-term outcome of PTE patients, in order to enhance clinical practice and establish a foundation of evidence for managing patients with PTE.

NCT Number	NCT06382038
Lead Sponsor	Navy General Hospital, Beijing
Conditions	Venous Thromboembolism, Pulmonary Thromboembolisms, Digital Health
Enrollment	2,972 participants
Start Date	2025-10-08
Primary Completion	2026-10-31 (estimated)
Study Completion	2026-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-31